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Abstract: Efficient and versatile synthetic methodologies are reported for the preparation of products
that are suitable candidates to be used as surfactants, gelators for hydroxylic solvents or metal cation
ligands, with potential use in several fields including biomedical applications. The common structural
feature of all the synthesized products is the presence of a cis or trans-1,2- or cis-1,3-difunctionalized
cyclobutane ring. In the two first cases, the key intermediates including enantiomerically pure
1,3-diamines and 1,3-amino alcohols have been prepared from β-amino acid derivatives obtained,
in turn, from a chiral half-ester. This compound is also precursor of γ-amino esters. Furthermore,
two kind of polydentate ligands have also been synthesized from a symmetric 1,5-diamine obtained
from norpinic acid, which was easily prepared from commercial verbenone.
Keywords: cyclobutane; amphiphiles; surfactants; gelators; cation ligands
1. Introduction
Search for new molecules with suitable properties for biological purposes needs a rational synthetic
design involving stereo- and chemoselective methodologies. Among target products, amphiphiles in
general and, especially, surfactants and gelators play a key role in biomedicine. In addition, appropriate
ligands to chelate cations are crucial for imaging technologies and radiopharmacy.
Amphiphiles are interesting and versatile compounds with usefulness in different fields. They can
be classified in different families regarding their structure. Single head–single tail amphiphiles consist
of an apolar tail and a polar head. Depending on the nature of the latter, they are classified as cationic,
anionic or non-ionic amphiphiles [1]. They present a great potential for biomedical applications in
targeted drug delivery systems (DDS) [1] and as non-viral vectors for gene therapy [2]. For the last
purpose, cationic surfactants are especially interesting due to the fact of their properties that make
them suitable to interact with DNA. Indeed, controlled DNA compaction and neutralization of their
negatively charged phosphate groups is crucial to transfect into cells avoiding repulsive interactions
with phospholipids in the cell membrane [3].
Otherwise, amphiphiles with properties as gelators and, in particular low-molecular-weight
gelators (LMWG) are also valuable for the design and preparation of soft materials with utility in
biochemical and biophysical studies [4] and applications in biomedicine, which include DDS, biosensors
and tissue regeneration [5].
Imaging is nowadays a powerful tool in diagnosis and personalized medicine. In this area,
contrast agents play a relevant role [6]. Many of them consist of appropriate metal complexes that
must present specific requirements to assure their thermodynamic and kinetic stability to avoid metal
leaching into the body. For this reason, the search for modifications in the structure of the ligands,
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trying to improve the properties and the effectiveness of the corresponding complexes, is the subject of
a very active interdisciplinary research [7].
Previously, we have developed efficient synthetic methodologies to prepare both 1,2- and
1,3- disubstituted cyclobutane derivatives, whose exploitation in the synthesis of several kinds of
amphiphiles [8–10], organogelators producing chiral aggregates [11,12] and metal ligands [13] has
been explored. The presence of the cyclobutane ring confers all these types of molecules with rigidity
as well as with two stereogenic centers, the relative and absolute configurations of which can be controlled.
Scheme 1 summarizes synthetic strategies to prepare some cis- and trans-1,2-cyclobutane derivatives
from a chiral half-ester that is the common precursor to cis- [14] and trans-β-amino acids [15,16]. From
these compounds, we synthesized peptides with properties as foldamers in solution [16–18] and/or
LMWG [19,20] as well as neuropeptide Y (NPY) analogues [21]. Amino alcohols [22] and diamines [22,23]
have also been prepared, some of them with application in organocatalysis [22,23]. The 1,3-diamine
motif is found in natural products and also in the structure of ligands for metal catalysts. Despite the
many synthetic methods described to prepare 1,2-diamine building blocks, the synthetic approaches to
1,3-diamines are more limited [24–26].
Scheme 1. Retrosynthetic strategies to prepare the target products from suitable precursors.
Concerning cis-1,3-disubstituted cyclobutane derivatives, we prepared organocatalysts [27] and
other products as dendrimers [28] and cell penetrating peptides [29] starting from commercial
verbenone, which provides polyfunctional chemical platforms that are highly useful scaffolds for
synthetic applications.
In this article, we describe the utilization of cis- and trans-cyclobutaneβ-amino acids (β-CBAA) [30]
in the stereoselective synthesis of novel chiral cationic surfactants and LMWG. Moreover, a new
synthesis of cis-γ-CBAA derivatives is provided along with their application as synthetic precursors to
anionic or non-ionic amphiphiles. Some examples are described herein to illustrate the usefulness of
these methodologies (Scheme 1).
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Moreover, highly rigid polydentate ligands for metal cations were synthesized as well from
norpinic acid [31], which is easily obtained from verbenone (Scheme 1) or pinene. Related ligands,
previously described in the literature, have formed gadolinium complexes with interesting properties
as potential candidates to contrast agents for magnetic resonance imaging [32–34], or complexes with
other cations of application in radiopharmacy [35] or for industrial purposes [36].
2. Results and Discussion
2.1. Amphiphiles from 1,2-Disubstituted Cyclobutane Scaffolds: Surfactants and LMWG
Scheme 1 shows two retrosynthetic strategies to prepare different families of single head–single
tail amphiphiles. Cationic derivatives were synthesized from 1,3-diamines and 1,3-amino alcohols,
respectively, as the immediate precursors. These compounds, in turn, were obtained from orthogonally
protected cis-β-CBAA through selective transformations of the functional groups. A second synthetic
route leads to the formation of cis-γ-CBAA as the key intermediates, which allows the preparation
of anionic or non-ionic amphiphiles. Moreover, trans-β-CBAA, obtained through regioselective
epimerization of the cis diastereomers, led to molecules which had structural features that conferred
on them possible properties as organogelators (Scheme 1). Indeed, these compounds bear functional
groups suitable for intermolecular hydrogen bonding and appropriate long alkyl-chains for van der
Waals interactions. In addition, trans stereochemistry precludes the formation of intramolecular
hydrogen bonds, thus favouring the interactions with solvents.
The synthetic route towards non-ionic or anionic amphiphiles is depicted in Scheme 2. The carboxyl
group in half-ester 1 [14] was selectively reduced with diborane in tetrahydrofuran, at 0 ◦C, providing
primary alcohol 2 in 63% yield, which was activated towards nucleophilic displacement to introduce
the amino group. Thus, treatment of 2 with tosyl chloride in the presence of triethylamine (TEA),
giving tosylate 3 in 77% yield, and subsequent reaction with sodium azide followed by hydrogenation
in the presence of 20% Pd(OH)2 on activated charcoal as a catalyst provided amino ester 4. Reaction
of this intermediate with lauryl chloride led to 5 in 51% yield (3 steps), which is representative of
non-ionic amphiphiles. Moreover, deprotection of the carboxyl group, by acid cleavage of the tert-butyl
ester with trifluoroacetic acid and triethylsilane in dichloromethane, afforded quantitatively 6, which
would be the direct precursor of an anionic amphiphile via deprotonation of the carboxylic acid.
Scheme 2. Synthetic route towards non-ionic or anionic amphiphiles.
Scheme 3 shows the synthetic pathways to prepare cationic amphiphiles 12 and 14 and LMWG 18
and 19 from cis- and trans-CBAA, respectively. The methyl ester in precursor 7 [14] was reduced with
lithium borohydride in ether to afford alcohol 8 in 75% yield. This compound was submitted to similar
transformations as those described above, giving diamine 10.
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Scheme 3. Synthesis of cationic amphiphiles and organogelators from cis- or trans-β-CBAA.
Separate reactions of amino alcohol 8 and diamine 10 with lauryl chloride and TEA under reflux
of dichloromethane led to compounds 11 and 13, respectively, in 66–68% yield. Treatment of these
products with 2 N HCl in dichloromethane allowed to obtain cationic surfactants 12 and 14 in 84% and
64%, respectively.
The synthetic route for the preparation of LMWG 16 and 17 (Scheme 3) starts with coupling of
previously described trans-β-CBAA 15 [15] with dodecyl- or hexadecylamine, using (benzotriazol-1-
yloxy)tripyrrolidinophosphonium hexafluorophosphate (PyBOP) as a coupling agent in the presence of
diisopropylethylamine (DIPEA) in dichloromethane, at room temperature, afforded the corresponding
amides that, in separate processes, were submitted to amine deprotection by treatment with HCl followed
of aqueous NaOH to provide the free amines. Further coupling with lauric or palmitic acid, under
similar conditions as before, led to diamides 16 and 17, respectively, in 27–28% yield from 15. Preliminary
experiments showed that these compounds are good gelators for alcohols (MeOH, EtOH, i-PrOH) with
minimum gelation concentration (mgc) values 8–47 mg/mL and biocompatible EtOH–water mixtures (up to
30% water) with mgc = 10–16 mg/mL. These data differentiate these LMWG from alkyl bisamides prepared
from cyclobutane-1,2-dicarboxylic acid, which were insoluble in alcohols [11], and confer these products
with very interesting features for future applications.
2.2. Highly Rigid Polydentate Ligands From 1,3-disubstituted Cyclobutane Scaffolds
1,5-Diamine 19 was synthesized from previously known dimesylate 18 (Scheme 4), which had
been obtained from norpinic acid [31]. The procedure was similar to that described above for the
preparation of amines 4 and 10.
Tetraalkylation of diamine 19 with tert-butyl bromoacetate, in the presence of KI and DIPEA,
using DMF as a solvent, afforded tetraester 20 in 26% yield. Tetraacid 21 was quantitatively obtained
after treatment of 20 with 4 M HCl in dioxane.
Otherwise, cyclic or open-chain ligands bearing picolinate moieties have shown enhanced ability
to coordinate metal cations making them useful for manifold applications including highly stable and
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kinetically inert contrast agents [33,34]. For this reason, we decided to synthesize ligand 25 according to
Scheme 4.
Scheme 4. Synthesis of ligands from 1,3-disubstituted cyclobutane scaffolds.
Methyl 6-formylpicolinate, 22 [37], was submitted to reductive amination by treatment with
0.5 equivalents of diamine 19 and subsequent in situ reduction of the resultant double Schiff-base with
sodium borohydride in methanol at 0 ◦C. Subsequent dialkylation was carried out as described before
for the preparation of 20, giving the analogue 24 in 11% yield for the two steps. Finally, saponification
of the two methyl esters with 1.2 equivalents of LiOH in a 1:1 THF/water mixture at room temperature
followed by treatment with 4 M HCl in dioxane, to remove the Boc protecting groups, led to ligand 25
in quantitative yield.
3. Materials and Methods
3.1. General Procedures
Melting points were determined using a Kofler apparatus model Reicher AustriaTM and are
uncorrected. Specific rotations were recorded on a JASCO-715 optical polarimeter. Infrared spectra
were recorded on a Bruker Tensor 27 spectrophotometer with sapphire-ATR (Golden Gate). Nuclear
magnetic resonance spectra were recorded on an AC 250, AVANCE 360, or ARX Bruker apparatus.
Mass spectra (MS) were obtained on a Bruker Squire 3000 micrOTOF spectrometer using ESI-MS
(QTOF). Thin-layer chromatography was performed using ALUGRAM® SIL G/UV254 aluminium
Int. J. Mol. Sci. 2019, 20, 4333 6 of 13
sheets pre-coated with silica gel 60 (0.20 mm thickness) containing a fluorescent indicator at 254 nm
(Macherey-Nagel, Düren, Germany). The TLC spots were visualized with a UV lamp or by staining
with vanillin in 96% EtOH or with an acid KMnO4 solution. Column chromatography was carried
out using PanReac® silica gel (230–400 mesh) (Castellar del Vallès, Spain). Nitrogen was used as
driving gas.
3.2. Experimental Section
3.2.1. Synthesis of tert-Butyl (1S,2R)-2-Hydroxymethylcyclobutane-1-Carboxylate (2)
1 M B2H6 in THF (10.5 mL, 10.5 mmol) was added to a solution of half-ester 1 [14] (1.4 g, 6.9 mmoL)
in anhydrous THF (70 mL) and the resultant mixture was stirred at 0 ◦C for 2 h under nitrogen
atmosphere and 2 h at room temperature. The reaction was quenched with aqueous saturated NH4Cl
(50 mL), then water (50 mL) was added and the mixture was extracted with EtOAc (4 × 80 mL).
The combined organic layers were dried over MgSO4 and solvent was removed at reduced pressure.
The residue was purified by flash chromatography (2:1 hexane/EtOAc) to afford alcohol 2 (0.85 g,
63% yield) as an oil. Rf = 0.27 (2:1 hexane/ethyl acetate); [α]D −21.7 (c = 1.01 in CH2Cl2); 1H NMR
(250 MHz, CDCl3) δ = 1.42 (s, 9H, OtBu); 1.68 (m, 1H, H3); 1.99 (m, 2H, H3, H4); 2.23 (m, 1H, H3); 2.73
(m, 1H, H2); 3.02 (m, 1H, OH); 3.16 (m, 1H, H1); 3.58 (m, 1H, H5); 3.71 (m, 1H, H5) ppm; 13C NMR
(62.5 MHz, CDCl3) δ = 21.3 (C3); 22.1 (C4); 28.4 (CBoc); 40.1 (C2); 41.2 (C1); 64.1 (C5); 81.3 (C7); 174.6
(C6) ppm; IR ν= 3411, 1720, 1152 cm−1; HRMS (ESI+) calcd m/z for C10H18O3 [M + Na]+: 209.1148,
found: 209.1152 (Supplementary Materials).
3.2.2. Synthesis of tert-Butyl (1R,2S)-2-Tosyloxymethylcyclobutane-1-Carboxylate (3)
A solution containing alcohol 2 (0.62 g, 3.3 mmol), p-toluenesulfonyl chloride (0.85 g, 4.3 mmol),
4-DMAP (0.1 g, 0.8 mmoL) and TEA (0.7 mL, 5.0 mmoL) in dry CH2Cl2 (30 mL) was stirred at room
temperature overnight under nitrogen atmosphere. Then water (100 mL) was added and the mixture
was extracted with CH2Cl2 (3 × 60 mL). Phases were separated and the organic layer was dried over
MgSO4. Solvent was removed and the residue was purified by flash column chromatography (3:1
hexane/EtOAc) to afford tosylate 3 (0.87 g, 77% yield) as an oil. Rf = 0.30 (3:1 hexane/EtOAc); [α]D
+223.6 (c = 1.03 in CH2Cl2); 1H NMR (360 MHz, CDCl3) δ = 1.41 (s, 9H, tBu); 1.72 (m, 1H, H3); 2.02
(m, 2H, H4, H3); 2.23 (m, 1H, H3); 2.44 (s, 3H, H7′); 2.88 (m, 1H, H1); 3.16 (m, 1H, H2); 4.13 (dd, 1H,
H5, J = 10.5 Hz, J’ = 7.2 Hz); 4.21 (dd, 1H, H5, J = 10.5 Hz, J’ = 7.2 Hz); 7.34 (d, J = 11.7 Hz, 2H, H3′,
H5′); 7.75 (d, J = 11.7 Hz, 2H, H2′, H6′); 13C NMR (90 MHz, CDCl3) δ = 21.0, 21.3, 21.4 (C4, C7′, C3);
27.7 (CBoc); 35.6 (C1); 39.8 (C2); 70.5 (C5); 80.7 (C7); 127.6 (C2′, C6′); 129.5 (C3′, C5′); 132.8 (C4′); 144.4
(C1′); 172.1 (C6); IR ν = 2979.3, 1721.17, 1600.6 cm−1; HRMS (ESI+) calcd m/z for C17H25NO5S [M +
Na]+: 363.1237, found: 363.1239.
3.2.3. Synthesis of tert-Butyl (1S,2R)-2-Dodecanamidomethylcyclobutane-1-Carboxylate (5) through
amine 4
A mixture of tosylate 3 (0.84 g, 2.4 mmol) and sodium azide (0.48 g, 7.4 mmol) in anhydrous DMF
(30 mL) was stirred and heated at 75 ◦C for 3 h under nitrogen atmosphere. Then EtOAc (60 mL) was
added and the resultant solution was washed with water (5 × 50 mL). The combined aqueous layers
were extracted with EtOAc (100 mL) and extract was washed with water (5 × 50 mL). The combined
organic layers were dried over MgSO4 and concentrated (caution: azides can be explosive, so their
solutions must be never evaporated to dryness). The residue was purified by column chromatography
(6:1 hexane/ethyl acetate) to afford yellowish oil (Rf = 0.44, 6:1 hexane/ethyl acetate). The obtained oil in
THF (20 mL) was hydrogenated under 1.9 atmospheres pressure in the presence of 20% Pd(OH)2/C as
a catalyst (0.10 g). After 5 h the mixture was filtered over celite® (Sigma-Aldrich, Darmstadt, Germany),
which was washed with methanol (30 mL). Solvents were removed to afford a solid corresponding
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to partially protected diamine 4 that was used in the next step without further purification due to
its instability.
A light protected solution of crude diamine 4 (0.10 g), dodecanoyl chloride (0.12 mL, 1.5 mmoL)
and TEA (0.16 mL, 1.9 mmoL) in dry CH2Cl2 (10 mL) was stirred overnight under nitrogen atmosphere.
The reaction mixture was successively washed with aqueous saturated NaHCO3 and brine. The organic
layer was dried over MgSO4 and solvent was evaporated to dryness. The residue was washed with
pentane affording compound 5 (0.1 g, 51% yield for the 3 steps) as a solid. m.p. 55–57 ◦C (pentane);
[α]D +10.7 (c= 1.06 in CH2Cl2); 1H NMR (250 MHz, CDCl3) δ = 0.90 (m, 3H, H12′); 1.28 (m, 16H, H4′,
H5′, H6′, H7′, H8′, H9′, H10′, H11′); 1.51 (s, 9H, tBu); 1.64 (m, 2H, H3′); 1.75 (m, 1H, H3); 2.07 (m, 2H,
H3, H4); 2.18 (m, 3H, H2′, H4); 2.80 (m, 1H, H2); 3.19 (m, 2H, H1, H5); 3.56 (m, 1H, H5); 6.10 (broad s,
1H, NH–C=O) ppm; 13C NMR (62.5 MHz, CDCl3) δ = 14.6 (C12′); 21.7–32.9 (C3, C4, C2′, C3′, C4′, C5′,
C6′, C7′, C8′, C9′, C11′); 28.7 (CBoc); 37.4, 38.2 (C2′, C2); 41.3, 41.8 (C1, C5); 81.3 (C7); 173.7 (C1′); 174.3
(C6) ppm; IR ν = 3328, 2916, 1715, 1644, 1153 cm−1; HRMS (ESI+) calcd m/z for C22H41NO3 [M + Na]+:
390.2979, found: 390.2981.
3.2.4. Synthesis of (1S,2R)-2-Dodecanamidomethylcyclobutane-1-Carboxylic Acid (6)
A solution containing ester 5 (90 mg, 0.2 mmol), TFA (0.25 mL, 3.8 mmoL), and triethylsilane
(0.10 mL, 0.6 mmol) in dry CH2Cl2 (5 mL) was stirred at room temperature overnight under nitrogen
atmosphere. Most of solvent was removed and the residue was lyophilized to afford acid 6 (74 mg,
quantitative yield) as a solid. m.p. 48–50 ◦C; [α]D +19.0 (c = 1.10 in CH2Cl2); 1H NMR (250 MHz,
CDCl3) δ = 0.90 (t, 3H, H12′, J = 6.8 Hz); 1.27 (m, 16H, H4′, H5′, H6′, H7′, H8′, H9′, H10′, H3′); 1.61
(m, 2H, H3′); 1.81 (m, 1H, H3); 2.12 (m, 2H, H3, H4); 2.21 (t., 2H, H2′, J = 6.7 Hz); 2.35 (m, 1H, H4);
2.90 (m, 1H, H2); 3.29 (m, 1H, H5); 3.46 (m, 2H, H5, H1); 6.36 (broad s, 1H, NH–C=O); 7.61 (broad s,
1H, HO–C=O) ppm; 13C NMR (62.5 MHz, CDCl3) δ = 14.5 (C12′); 21.2 (C3); 23.1 (C4); 26.2–32.3 (C3′,
C4′, C5′, C6′, C7′, C8′, C9′, C10′, C11′); 37.0 (C2′); 38.0 (C2); 40.7 (C5); 41.7 (C1); 175.1 (C1′); 178.6 (C6)
ppm; IR ν = 3309, 1740, 1702, 1174 cm−1.
3.2.5. Synthesis of tert-Butyl (1S,2R)-2-Hydroxymethylcyclobutane-1-Carbamate (8)
A solution of 2 M LiBH4 in THF (2.6 mL, 5.2 mmol) was added to a solution of amino ester 7
(1 g, 4.4. mmol) in Et2O (100 mL). The mixture was stirred at 0 ◦C for 3 h under nitrogen atmosphere.
Aqueous saturated NH4Cl was added (60 mL) and the resultant mixture was stirred for 30 min, then
water (50 mL) was added and the mixture was consecutively extracted with EtOAc (3 × 80 mL);
the organic layer was dried over MgSO4 and evaporated to dryness. The residue was chromatographed
on silica gel (3:1 hexane/EtOAc) to afford alcohol 8 (0.67 g, 75%) as a solid (Rf = 0.24, 3:1 hexane/EtOAc);
crystals, m.p. 79–81 ◦C (hexane/EtOAc); [α]D −77.8 (c = 1.02 in CH2Cl2); 1H NMR (250 MHz, CDCl3)
δ = 1.46 (s, 9H, tBu); 1.63 (m, 1H, H3); 1.88 (m, 2H, H4, H3); 2.36 (m, 1H, H4); 2.71 (m, 1H, H2); 3.63
(dd, 1H, H5, J = 11.3 Hz, J’ = 4.3 Hz); 3.78 (dd, 1H, H5, J = 11.3 Hz, J’ = 4.3 Hz); 3.75 (m, 1H); 4.21 (m,
1H, H1); 5.12 (broad s, 1H, NHBoc) ppm; 13C NMR (62.5 MHz, CDCl3) δ = 19.2 (C3); 28.8 (C4); 28.7
(CBoc); 41.9 (C2); 48.1 (C1); 62.8 (C5); 80.1 (C7); 156.9 (C6) ppm; IR ν = 3311, 2976, 1691, 1174 cm−1;
HRMS (ESI+) calcd m/z for C10H19NO3 [M + Na]+: 224.1257, found: 224.1260.
3.2.6. Synthesis of (1S,2R)-1-tert-Butyloxycarbonylaminocyclobutane-1-Methyl Dodecanoate (11)
A solution of alcohol 8 (0.3 g, 1.5 mmoL), lauryl chloride (0.36 mL, 1.5 mmoL), and TEA (0.27 mL,
1.9 mmoL) in dry CH2Cl2 (15 mL) was heated to reflux overnight under nitrogen atmosphere.
The reaction mixture was cooled to room temperature, washed once with aqueous saturated NaHCO3
(10 mL) and twice with brine, and dried over MgSO4. Solvent was removed and the residue was
purified by flash chromatography (CH2Cl2) to give pure 11 (0.4 g, 68%) as a solid. m.p. 44–46 ◦C
(CH2Cl2); [α]D −63.9 (c = 0.97 in CH2Cl2); 1H NMR (360 MHz, CDCl3) δ = 0.87 (t, 3H, H12′, J = 8.4 Hz);
1.25 (m, 16H, H4′, H5′, H6′, H7′, H8′, H9′, H10′, H11′); 1.43 (s, 9H, tBu); 1.63 (m, 3H, H4, H3′); 1.92 (m,
2H, H3, H4); 2.33 (m; 3H, H2′, H3); 2.81 (m, 1H, H1); 4.16 (dd, 1H, H5, J = 13.8 Hz, J’ = 7.2 Hz); 4.31 (dd,
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1H, H5, J = 13.8 Hz, J’ = 7.2 Hz); 4.30 (m, 1H, H2); 4.79 (broad s, 1H, NHBoc) ppm; 13C NMR (90 MHz,
CDCl3) δ = 13.8 (C12′); 17.7 (C4); 22.2–31.6 (C3′, C4′, C5′, C6′, C7′, C8′, C9′, C10′, C11′); 26.6 (C4); 28.1
(CBoc); 34.1 (C2′); 38,6 (C1); 45.8 (C2); 63.4 (C5); 79.0 (C7); 154.7 (C6); 173.7 (C1′) ppm; IR ν = 3342,
2919, 1679, 1166 cm−1; HRMS (ESI+) calcd m/z for C22H41NO4 [M + Na]+: 406.2928, found: 406.2930.
3.2.7. Synthesis of (1S,2R)-2-Dodecanoyloxymethylcyclobutane-1-Ammonium Chloride (12)
A solution of compound 11 (0.2 g, 0.5 mmol) and 2 N HCl in Et2O (1.56 mL, 3.1 mmol) in dry
CH2Cl2 (15 mL) was stirred at room temperature for 24 h under nitrogen atmosphere. Most solvent
was removed, and the residue was lyophilized to afford quantitatively a solid that was crystallized in
pentane to provide surfactant 12 (0.14 g, 84% yield) as crystals. m.p. 86–88 ◦C (pentane); [α]D +9.6
(c = 1.01 in MeOH); 1H NMR (360 MHz, CD3OD) δ = 0.91 (m, 3H, H12′); 1.30 (m, 16H, H4′, H5′, H6′,
H7′, H8′, H9′, H10′, H11′); 1.63 (m, 2H, H3′); 1.81 (m, 1H, H3); 2.17 (m, 2H, H4, H3); 2.39 (m, 3H,
H2′, H4); 2.95 (m, 1H, H2); 3.95 (m, 1H, H1); 4.32 (m, 2H, H5); 13C NMR (90 MHz, CD3OD) δ = 13.1
(C12′); 17.9 (C3); 22.3–29.3 (C3′, C4′, C5′, C6′, C7′, C8′, C9′, C10′, C11′); 31.7 (C4); 33.4 (C2′); 36.4 (C2);
46.6 (C5); 62.3 (C1); 173.8 (C1′) ppm; IR ν = 3370, 2919, 1740, 1112 cm−1; HRMS (ESI+) calcd m/z for
C17H34ClNO2 [M]+: 319.2348, found: 319.2346.
3.2.8. Synthesis of tert-Butyl (1S,2R)-2-Tosyloxymethylcyclobutane-1-Carboxylate (9)
Following a procedure similar to that described above for the preparation of tosylate 3, compound
9 (0.57 g, 62% yield) was obtained as a solid. Rf = 0.28 (6:1 hexane/EtOAc); crystals, m.p. 87–88 ◦C
(ethyl acetate/hexane); [α]D −102.9 (c = 1.05 in CH2Cl2); 1H NMR (360 MHz, CDCl3) δ = 1.41 (s, 9H,
tBu); 1.58 (m, 1H, H3); 1.88 (m, 2H, H4, H3); 2.27 (m, 1H, H3); 2.45 (s, 3H, H7′); 2.75 (m, 1H, H1); 4.17
(m, 2H, H5); 4.33 (m, 1H, H2); 4.77 (broad s, 1H, NHBoc); 7.34 (d, J = 11.7 Hz, 2H, H3′, H5′); 7.75 (d,
J = 11.7 Hz, 2H, H2′, H6′) ppm; 13C NMR (90 MHz, CDCl3) δ = 17.6 (C4); 21.4 (C7′); 28.0 (CBoc); 28.1
(C3); 38.7 (C1); 45.8 (C2); 69.8 (C5); 79.1 (C7); 127.6 (C2′, C6′); 129.6 (C3′, C5′); 132.6 (C4′); 144.6 (C1′);
154.8 (C6) ppm; IR: ν = 3311, 2976, 1691, 1174 cm−1; HRMS (ESI+) calcd m/z for C17H25NO5S [M +
Na]+: 378.1346, found: 378.1344.
3.2.9. Synthesis of tert-Butyl (1S,2S)-2-Dodecanamidomethylcyclobutane-1-Carbamate (13) through
diamine 10
Following a similar procedure than that described above for the preparation of 5, compound 13
(66% overall yield for the three steps) was obtained as crystals. m.p. 102-104 ◦C (pentane); [α]D −40.2
(c = 1.01 in CH2Cl2); 1H NMR (360 MHz, CDCl3) δ = 0.89 (t, 3H, H12′, J=5.7 Hz); 1.25 (m, 16H, H4′,
H5′, H6′, H7′, H8′, H9′, H10′, H11′); 1.44 (s, 9H, tBu); 1.61 (m, 3H, H3, H3′); 1.80 (m, 1H, H4); 1.92 (m,
1H, H3); 2.13 (t., 2H, H2′, J = 6.3 Hz); 2.36 (m, 1H, H4); 2.59 (m, 1H, H2); 3.15 (m, 1H, H5); 3.52 (m, 1H,
H5); 4.17 (m, 1H, H1); 4.99 (broad s, 1H, NHBoc); 6.12 (broad s, 1H, NH-C=O) ppm; 13C NMR (90 MHz,
CDCl3) δ = 14.1 (C12′); 20.1 (C3); 26.6 (C4); 22.7–29.6 (C2′, C3′, C4′, C5′, C6′, C7′, C8′, C9′, C11′); 28.4
(CBoc); 36.9 (C10′); 39.1–40.0 (C2, C5); 47.2 (C1); 79.7 (C7); 156.2 (C6); 173.3 (C1′) ppm; IR ν = 3342,
2919, 1679 cm−1; HRMS (ESI+) calcd m/z for C22H42N2O3 [M + Na]+: 405.3088, found: 405.3088.
3.2.10. Synthesis of (1S,2R)-2-Dodecanamidomethylcyclobutane-1-Ammonium Chloride (14)
A solution of compound 13 (0.2 g, 0.5 mmol) and 2 N HCl in Et2O (1.56 mL, 3.1 mmol) in dry
CH2Cl2 (15 mL) was stirred at room temperature for 24 h under nitrogen atmosphere. Most solvent
was removed, and the residue was lyophilized to afford quantitatively a solid that was crystallized in
pentane to provide amphiphile 14 (0.1 g, 64% yield). Crystals, m.p. 98–100 ◦C (pentane); [α]D +8.7
(c = 1.05 in MeOH); 1H NMR (360 MHz, CD3OD) δ = 0.91 (m, 3H, H12′); 1.30 (m, 16H, H4′, H5′, H6′,
H7′, H8′, H9′, H10′ H11′); 1.61 (m, 2H, H3′); 1.98 (m, 2H, H3, H4); 2.09 (m, 1H, H3); 2.23 (t, 2H, H2′,
J=6.3 Hz); 2.39 (m, 1H, H4); 2.79 (m, 1H, H1); 3.16 (m, 1H, H5); 3.44 (m, 1H, H5); 3.75 (m, 1H, H1) ppm;
13C NMR (90 MHz, CD3OD) δ = 13.0 (C12′); 20.2 (C3); 22.3 (C4); 22.7–29.6 (C3′, C4′, C5′, C6′, C7′, C8′,
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C9′, C10′, C11′); 35.5 (C2′); 37.8–38.6 (C2, C5); 47.2 (C1); 176.2 (C1′) ppm; IR ν = 3342, 2918, 1679 cm−1;
HRMS (ESI+) calcd m/z for C17H35N2O [M]+: 283.2744, found: 283.2745.
3.2.11. Synthesis of Diamides 16 and 17. General Procedure
To a solution of compound 15 [15] (0.18 g, 0.84 mmol) in anhydrous CH2Cl2 (27.0 mL), DIPEA
(0.44 mL, 2.52 mmoL) and PyBOP (0.55 g, 1.06 mmoL) were added. After 15 min stirring at room
temperature, dodecylamine or hexadecylamine (0.92 mmoL) dissolved in anhydrous CH2Cl2 (10.0 mL)
was added and the resulting mixture was stirred at room temperature for 18 h. The solution was
diluted with CH2Cl2 (10.0 mL) and washed with aqueous saturated NaHCO3 (30.0 mL). The organic
layer was dried over MgSO4 and evaporated under vacuum. The residue was purified by column
chromatography (1:1 hexane-EtOAc) to afford the corresponding pure amide. A mixture containing
this compound (0.40 mmoL), 2 N HCl in Et2O (20 mmoL) and anhydrous CH2Cl2 (10.0 mL) was
stirred at room temperature for 36 h. The solvent was evaporated at reduced pressure to afford the
corresponding amine hydrochloride, which was dissolved in a 1:1 mixture of 0.25 M NaOH-CH2Cl2
and stirred vigorously for 15 min. Then the reaction mixture was extracted with CH2Cl2 (3 × 10 mL).
The combined organic layers were dried over MgSO4 and solvent was removed to afford the respective
free amine. This was coupled with lauryl or palmitic acid, respectively, as described above for the
first coupling procedure. After purification by column chromatography (5% MeOH-CH2Cl2) the
corresponding pure diamides were obtained as solid products.
(1S,2S)-N-Dodecyl-2-Dodecanamidocyclobutane-1-Carboxamide (16)
27% overall yield from 15. Crystals, m.p. 74–79 ◦C (CH2Cl2); [α]D +2.1 (c = 1.05 in CH2Cl2); 1H
NMR (360 MHz, CDCl3) δ = 0.92 (t, J = 6.4 Hz, 6H, H19, H18′), 1.28 (s, 34H, H10-18, H10′-17′), 1.60 (m,
4H, H9, H9′), 1.81–2.00 (m, 2H, H4-3), 2.19 (m, 4H, H3-4, H8′), 2.90 (q, J = 9.1 Hz, 1H, H5), 3.24 (m,
2H, H8), 4.33 (m, 1H, H2), 5.88 (broad s, 1H, N1H), 8.36 (broad s, 1H, N7H) ppm; 13C NMR (90 MHz,
CDCl3) δ = 13.8 (C19, C19′); 18.6 (C4); 22.3 (C18, C18′); 24.1 (C9-16,C10′-16′); 25.4 (C9-16, C10′-16′);
26.8 (C3); 29.0-29.4 (C9-16,C10′-16′); 31.7 (C17,C17′); 36.1 (C17, C17′); 39.1 (C8); 47.7 (C2); 49.7 (C5, C9′);
172.5 (C7); 174.1 (C8′) ppm; IR ν = 2952, 1685, 1638 cm−1; HRMS (ESI+) calcd m/z for C29H56N2O2 [M +
H]+: 465.4415, found: 465.4397.
(1S,2S)-N-Hexadecyl-2-Palmitamidocyclobutane-1-Carboxamide (17)
28% overall yield from 15. Crystals, m.p. 116-118 ◦C (CH2Cl2); [α]D +6.0 (c = 1.04 in CH2Cl2); 1H
NMR (360 MHz, CDCl3) δ = 0.88 (t, J = 5.5 Hz, 6H, H23, H22′), 1.26 (s, 50H, H10-22, H10′-21′), 1.61 (m,
4H, H9, H9′), 1.77–2.00 (m, 2H, H4-3), 2.18 (m, 4H, H3-4, H8′), 2.89 (q, J = 8.7 Hz, 1H, H5), 3.21 (m, 2H,
H8), 4.32 (m, 1H, H2), 5.80 (d, J = 6.6 Hz, 1H, N1H), 8.34 (s, 1H, N7H) ppm; 13C NMR (90 MHz, CDCl3)
δ = 13.9 (C23, C23′); 18.6 (C4); 22.2 (C22, C22′); 24.1 (C9-20, C10′-20′); 25.4 (C9-20, C10′-20′); 26.8 (C3);
29.0–29.4 (C9-20, C10′-20′); 31.6 (C21, C21′); 39.3 (C8); 47.4 (C2); 49.7 (C5, C9′); 172.2 (C7); 173.9 (C8′)
ppm; IR ν = 3293, 2955, 2849, 1686, 1644 cm−1; HRMS (ESI+) calcd m/z for C37H72N2O2 [M + Na]+:
599.5486, found: 599.5478.
3.2.12. Synthesis of Tetra-tert-Butyl N,N,N’,N’-[((1S,3R)-2,2-Dimethylcyclobutane-1,3-diyl)
Bis(Methylene)Bis(Azanetriyl)] Tetraacetate (20)
Diamine 19 was prepared from dimesylate 18 [31] as described above for the synthesis of diamine
4 and used in the next step without further purification. tert-Butyl bromoacetate (3.7 mL, 25.1 mmoL)
was added dropwise to a mixture of crude diamine 19 (0.45 g, 3.2 mmoL), potassium iodide (2.8 g, 17
mmoL), and DIPEA (8.7 mL, 50.2 mmoL) in anhydrous DMF (15 mL). The resultant solution was stirred
at room temperature for 96 h under nitrogen atmosphere. The mixture was diluted with dichloromethane
(150 mL) and washed with sat. K2CO3 (2 × 30 mL) and brine (40 mL). The organic phase was dried over
MgSO4 and the solvent was evaporated to afford a yellow oil. The crude product was purified by column
chromatography (4:1 Hexane/EtOAc) to obtain a colourless oil (0.48 g, 26% overall yield from dimesylate
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18). 1H NMR (250 MHz, CDCl3) δ = 0.92 (s, 3H, H6/5); 1.09 (s, 3H, H5/6); 1.47 (s, 36H, H11); 2.06 (m, 3H,
H1, H3, H4); 2.66 (m, 4H, H7); 3.39 (s, 8H, H8); ppm; 13C NMR (62.5 MHz, CDCl3) δ = 16.0 (C6); 28.0
(C5); 29.6 (C11); 30.0 (C2); 40.0 (C4); 40.9 (C1, C3); 54.5 (C7); 55.9 (C8); 80.8 (C10); 170.7 (C9) ppm; IR ν =
1727, 1146 cm−1; HRMS (ESI+) calcd m/z for C32H58N2O8 [M + H]+: 599.4266, found: 599.4252.
3.2.13. Synthesis of N,N,N’,N’-[((1S,3R)-2,2-dimethylcyclobutane-1,3-diyl)
bis(methylene)-bis(azanetriyl)] tetraacetic acid (21)
A solution of tetraester 20 (0.20 g, 0.3 mmoL) in 4 M HCl in dioxane (12 mL, 48 mmoL) was stirred
at room temperature for 20 h. Solvent was removed at reduced pressure, then water (2 mL) was added
and the mixture was lyophilized to afford 21 as a solid (0.13 g, quantitative). 1H NMR (250 MHz,
CDCl3) δ = 0.85 (s, 3H, H5/6); 1.03 (s, 3H, H5/6), 1.14–1.29 (m, 1H, H4); 1.94–2.11 (m, 3H, H1,3,4); 2.48
(m, 2H, H7); 2.62 (m, 2H, H7); 3.95 (s, 6H, H15); 3.77–4.06 (m, 4H, H8); 7.54 (m, 2H, H9); 7.77 (m, 2H,
H10); 7.97 (m, 2H, H11) ppm; 13C NMR (62.5 MHz, CDCl3) δ = 15.1 (C6); 27.6 (C5); 29.5 (C4); 37.0
(C2); 41.2 (C3); 55.5 (C7); 56.9 (C8); 168.7 (C9) ppm; IR ν = 1730 cm−1; HRMS (ESI+) calcd m/z for
C16H26N2O8 [M - H]−: 373.1616, found: 373.1626.
3.2.14. Synthesis of Dimethyl 6,6′-[{2,2-Dimethylcyclobutane-1,3-diylbis[(2-tert-butoxy-2-oxoethyl)-
azanemethylenediyl]}bis(methylene)] dipicolinate (24) through compound (23)
A solution of diamine 19 (0.6 g, 4.3 mmol) and methyl 6-formyl picolinate 22 [37] (0.14 g, 8.6
mmoL) in MeOH (20 mL) was stirred at room temperature for 5 h. Then, the solution was cooled with
ice and NaBH4 (0.26 g, 7 mmoL) and MeOH (20 mL) were added. The resultant ice-cooled mixture
was stirred for 2 h. Aqueous saturated NaHCO3 (30 mL) was added and most methanol was removed.
The solution was extracted with CH2Cl2 (4 × 50 mL), the combined organic layers were dried over
MgSO4 and solvent was removed to afford crude compound 23 that was identified by its 1H NMR
spectrum and used in the next step without further purification. 1H NMR (250 MHz, CDCl3) δ = 0.91
(s, 3H, H4/5); 1.09 (s, 3H), 1.14–1.29 (m, 1H, H1); 1.94-2.11 (m, 3H, H1,2,3); 2.48 (m, 2H, H6/7); 2.62 (m,
2H, H6/7); 3.95 (s, 6H, H12); 3.77–4.06 (m, 4H, H8); 7.54 (d, J = 7.8 Hz, 2H, H9/11); 7.77 (t, J = 7.7 Hz,
2H, H10); 7.97 (d, J = 7.7 Hz, 2H, H9/11).
Using the same procedure as that described above to prepare 20, crude 23 (0.5 g) was made to react
with tert-butyl bromoacetate affording a reaction crude, which was purified by column chromatography
(3:1 to 1:1 hexane/EtOAc) affording tetraester 24 (0.35 g, 11% yield for the two steps) as a yellowish oil.
1H NMR (400 MHz, CDCl3) δ = 0.63 (s, 3H, H5/6); 0.88 (s, 3H, H5/6); 1.13 (m, 1H, H4); 1.28 (s, 18H,
H19); 1.88 (m, 3H, H1,3,4); 2.44 (m, 4H, H7); 3.07 (m, 4H, H8/16); 3.79 (m, 4H, H8/16); 3.82 (s, 6H, H15);
7.68 (m, 4H, H10,11); 7.84 (m, 2H, H12) ppm; 13C NMR (62.5 MHz, CDCl3) δ = 15.8 (C5,6); 27.9 (C19);
29.3 (C4); 29.9 (C5,6); 39.6 (C3/11); 40.3 (C2); 40.5 (C1,3); 52.5 (C7); 54.8 (C15); 56.1 (C16); 60.2 (C8);
80.6 (C18); 123.2 (C10); 125.7 (C12); 137.0 (C11); 146.8 (C13); 160.9 (C9); 165.6 (C14); 170.2 (C17) ppm; IR
ν = 2951, 2862, 2360, 1723, 1139 cm−1; HRMS (ESI+) calcd m/z for C36H52N4O8 [M + H]+: 669.3858,
found: 669.3853.
3.2.15. Synthesis of 6,6′-[{2,2-dimethylcyclobutane-1,3-diylbis[(carboxymethyl) azane methylene diyl]}-
bis(methylene)] dipicolinic acid (25)
A mixture containing compound 24 (200 mg, 0.30 mmol) and LiOH (45 mg, 1.19 mmoL) in 1:1
THF/H2O (5 mL) was stirred at room temperature for 4 h. Solvent was removed, the residue was
poured into 4 M HCl in dioxane (8 mL) and the mixture was stirred for 20 h. Solvent was evaporated
under vacuo, water (2 mL) was added and the resultant mixture was lyophilized to afford quantitatively
tetraacid 25 (170 mg) as a brown solid. 1H NMR (250 MHz, D2O) δ = 0.78 (s, 3H, H5/6), 0.97 (s, 3H,
H5/6), 1.78 (m, 1H, H4), 2.10 (m, 1H, H1/3/4), 2.30 (m, 2H, H1/3/4), 3.32 (m, 4H, H7), 3.98 (s, 4H, H8/16),
4.57 (s, 4H, H8/16), 7.62 (d, J = 7.6 Hz, 2H, H10), 8.00 (t, J = 7.7 Hz, 2H, H11), 8.09 (d, J = 7.7 Hz, 2H,
H12) ppm; 13C NMR (62.5 MHz, D2O) δ = 14.8 (C5,6); 27.4 (C4); 29.5 (C5,6); 36.7 (C1/3); 41.0 (C2); 54.1
(C7); 56.2 (C16); 27.8 (C8); 125.4 and 127.8 (C10/12); 139.8 (C11); 146.2 (C13); 149.1 (C9); 166.8 and 167.7
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(C14/17) ppm; IR ν = 3363, 2360, 1730, 1630, 1400 cm−1; HRMS (ESI+) calcd m/z for C26H32N4O8 [M +
H]+: 529.2293, found: 529.2283.
4. Conclusions
In this work, we showed the suitability of several cyclobutane scaffolds for the preparation
of different families of products with potential usefulness in the fields of surfactants, gelators and
metal cation ligands. Enantiomerically pure cis-1,2-disubstitued cyclobutane derivatives have been
efficient and selectively obtained from a common chiral half-ester. From this precursor, synthetic routes
to amphiphiles as possible surfactants have been achieved through a cis-β-CBAA as a convenient
intermediate. In addition, compounds with appropriate structures to behave as gelators have been
synthesized from an orthogonally protected trans-β-CBAA. Otherwise, symmetric cis-1,3-cyclobutane
scaffolds have been prepared from verbenone through norpinic acid that provided a cis-1,5-diamine,
which is a key intermediate in the synthesis of different poly(amino acids). These compounds are
valuable candidates to be investigated as polydentate ligands for lanthanide complexes. The properties
of these families of compounds as well as their likely applications are the subject of active investigation
in our laboratory.
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Abbreviations
ATR Attenuated Total Reflection
CBAA Cyclobutane Amino Acid
DDS Drug Delivery Systems
DIPEA Diisopropylethylamine
DMAP Dimethylaminopyridine
DMF Dimethylformamide
DNA Deoxyribonucleic Acid
ESI Electrospray Ionization
HRMS High-Resolution Mass Spectrometry
IR Infrared
LMWG Low Molecular-Weight Gelator
MS Mass Spectrometry
NMR Nuclear Magnetic Resonance
NPY Neuropeptide Y
PyBOP (Benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate
QTOF Quadrupole Time-of-Flight
TEA Triethylamine
TFA Trifluoroacetic Acid
THF Tetrahydrofuran
TLC Thin layer chromatography
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